Skip to Content
Home > About Us > Research and Grants Administration > Results
This randomized phase III trial is studying giving patients oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) together to compare how well they work when given together with or without celecoxib in treating patients with stage III colon cancer previously treated with surgery.
This study will also compare the effects (good and bad) of a combination of chemotherapy drugs, when given with and without a new drug, bevacizumab, on patients with stage II colon cancer at high-risk for recurrence.
View Additional Section Content
For more information about our research program and IRB, please contact: